NO20052515L - Frigjoringskontrollerte sammensetninger - Google Patents
Frigjoringskontrollerte sammensetningerInfo
- Publication number
- NO20052515L NO20052515L NO20052515A NO20052515A NO20052515L NO 20052515 L NO20052515 L NO 20052515L NO 20052515 A NO20052515 A NO 20052515A NO 20052515 A NO20052515 A NO 20052515A NO 20052515 L NO20052515 L NO 20052515L
- Authority
- NO
- Norway
- Prior art keywords
- release
- matrix
- agent
- release controlled
- core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En fast doseringsformulering med en kjerne med et farmakologisk middel dispergert i en første frigjøringskontrollert matrise hvorfra frigjøringen av middelet skjer relativt langsomt; og et belegg dannet over kjernen og med et middel dispergert i en andre frigjøringskontrollert matrise hvorfra frigjøringen av middelet skjer relativt raskt. Den første matrisen kan være en kryssbundet amyloserik stivelse og den andre matrisen kan være en blanding av polyvinylacetat og polyvinylpyrrolidon.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28102602A | 2002-10-25 | 2002-10-25 | |
US50906202P | 2002-10-25 | 2002-10-25 | |
PCT/CA2003/001637 WO2004038428A2 (en) | 2002-10-25 | 2003-10-27 | Controlled-release compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052515D0 NO20052515D0 (no) | 2005-05-25 |
NO20052515L true NO20052515L (no) | 2005-05-25 |
Family
ID=34976756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052515A NO20052515L (no) | 2002-10-25 | 2005-05-25 | Frigjoringskontrollerte sammensetninger |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1558935B1 (no) |
JP (1) | JP2006507276A (no) |
KR (1) | KR101120729B1 (no) |
AT (1) | ATE400819T1 (no) |
AU (1) | AU2003275854B9 (no) |
BR (1) | BR0315657A (no) |
CA (1) | CA2503361C (no) |
DE (1) | DE60322091D1 (no) |
DK (1) | DK1558935T3 (no) |
EC (1) | ECSP055748A (no) |
ES (1) | ES2310686T3 (no) |
HK (1) | HK1086475A1 (no) |
MX (1) | MXPA05004410A (no) |
NO (1) | NO20052515L (no) |
NZ (1) | NZ539869A (no) |
PT (1) | PT1558935E (no) |
RU (1) | RU2333745C2 (no) |
SI (1) | SI1558935T1 (no) |
WO (1) | WO2004038428A2 (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
JP2005306778A (ja) * | 2004-04-21 | 2005-11-04 | Basf Ag | 徐放性製剤及びその製造方法 |
US8461187B2 (en) | 2004-06-16 | 2013-06-11 | Takeda Pharmaceuticals U.S.A., Inc. | Multiple PPI dosage form |
CA2491665A1 (fr) * | 2004-12-24 | 2006-06-24 | Louis Cartilier | Formulation de comprime pour liberation soutenue de principe actif |
EP1917000A2 (en) | 2005-07-07 | 2008-05-07 | Farnam Companies, Inc. | Sustained release pharmaceutical compositions for highly water soluble drugs |
PL1931346T3 (pl) | 2005-09-09 | 2013-01-31 | Angelini Labopharm Llc | Kompozycja trazodonu do podawania raz na dobę |
CN100437113C (zh) * | 2006-04-11 | 2008-11-26 | 汪运山 | 一种检测血液中非那西丁与醋氨酚浓度比值的试剂盒 |
AU2013202441B2 (en) * | 2006-04-26 | 2016-02-25 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
US20090169617A1 (en) * | 2006-04-26 | 2009-07-02 | Panagiotis Keramidas | Controlled Release Formulations Comprising Uncoated Discrete Unit(s) and an Extended Release Matrix |
CN100387988C (zh) * | 2006-07-25 | 2008-05-14 | 山东省医药工业研究所 | 一种布洛伪麻那敏复方制剂的含量检测方法 |
WO2008095263A1 (en) | 2007-02-09 | 2008-08-14 | Alphapharm Pty Ltd | A dosage form containing two or more active pharmaceutical ingredients in different physical forms |
EP2203166B1 (en) | 2007-10-16 | 2015-05-06 | Paladin Labs Inc. | Bilayer composition for the sustained release of acetaminophen and tramadol |
NZ589742A (en) | 2008-05-27 | 2012-06-29 | Univ Melbourne | Methods of treating mammals with eustachian tube dysfunctions with betahistine |
US20120065221A1 (en) | 2009-02-26 | 2012-03-15 | Theraquest Biosciences, Inc. | Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use |
ES2569925T3 (es) | 2009-09-30 | 2016-05-13 | Acura Pharmaceuticals, Inc. | Métodos y composiciones de disuasión del abuso |
US20130039864A1 (en) * | 2010-04-23 | 2013-02-14 | Francois Ravenelle | Non-Intravenous Dosage Form Comprising Solid Formulation of Liquid Biologically Active Agent and Uses Thereof |
RU2451680C1 (ru) | 2011-02-21 | 2012-05-27 | Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" | Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство |
RU2673818C2 (ru) | 2012-11-30 | 2018-11-30 | Экьюра Фармасьютикалз, Инк. | Саморегулируемое высвобождение фармацевтического ингредиента |
WO2017040607A1 (en) | 2015-08-31 | 2017-03-09 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
CN114177155B (zh) * | 2020-09-08 | 2023-10-03 | 越洋医药开发(广州)有限公司 | 一种布洛芬控释片及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ260408A (en) * | 1993-05-10 | 1996-05-28 | Euro Celtique Sa | Controlled release preparation comprising tramadol |
DE19530575A1 (de) * | 1995-08-19 | 1997-02-20 | Gruenenthal Gmbh | Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz |
CA2173818A1 (fr) * | 1996-04-10 | 1997-10-11 | Francois Chouinard | Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose |
AU8293498A (en) * | 1997-07-02 | 1999-01-25 | Euro-Celtique S.A. | Stabilized sustained release tramadol formulations |
US6284273B1 (en) * | 1998-02-24 | 2001-09-04 | Vincent Lenaerts | Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds |
DE10014588A1 (de) * | 2000-03-27 | 2001-10-04 | Basf Ag | Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung |
DE10015479A1 (de) * | 2000-03-29 | 2001-10-11 | Basf Ag | Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität |
US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
KR100507946B1 (ko) * | 2001-01-31 | 2005-08-17 | 룀 게엠베하 운트 콤파니 카게 | 상이하게 피복된 펠렛 형태를 두 가지 이상 포함하는 다중 입상형 약제 |
-
2003
- 2003-10-27 DE DE60322091T patent/DE60322091D1/de not_active Expired - Lifetime
- 2003-10-27 RU RU2005115883/15A patent/RU2333745C2/ru not_active IP Right Cessation
- 2003-10-27 DK DK03809236T patent/DK1558935T3/da active
- 2003-10-27 CA CA2503361A patent/CA2503361C/en not_active Expired - Fee Related
- 2003-10-27 EP EP03809236A patent/EP1558935B1/en not_active Expired - Lifetime
- 2003-10-27 AT AT03809236T patent/ATE400819T1/de active
- 2003-10-27 PT PT03809236T patent/PT1558935E/pt unknown
- 2003-10-27 AU AU2003275854A patent/AU2003275854B9/en not_active Expired
- 2003-10-27 ES ES03809236T patent/ES2310686T3/es not_active Expired - Lifetime
- 2003-10-27 KR KR1020057007088A patent/KR101120729B1/ko active IP Right Grant
- 2003-10-27 NZ NZ539869A patent/NZ539869A/en not_active IP Right Cessation
- 2003-10-27 BR BR0315657-5A patent/BR0315657A/pt active IP Right Grant
- 2003-10-27 JP JP2004545654A patent/JP2006507276A/ja not_active Withdrawn
- 2003-10-27 SI SI200331377T patent/SI1558935T1/sl unknown
- 2003-10-27 WO PCT/CA2003/001637 patent/WO2004038428A2/en active IP Right Grant
- 2003-10-27 MX MXPA05004410A patent/MXPA05004410A/es active IP Right Grant
-
2005
- 2005-04-25 EC EC2005005748A patent/ECSP055748A/es unknown
- 2005-05-25 NO NO20052515A patent/NO20052515L/no not_active Application Discontinuation
-
2006
- 2006-06-02 HK HK06106374A patent/HK1086475A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1558935B1 (en) | 2008-07-09 |
RU2005115883A (ru) | 2006-01-27 |
RU2333745C2 (ru) | 2008-09-20 |
CA2503361C (en) | 2012-02-28 |
KR20050088281A (ko) | 2005-09-05 |
DK1558935T3 (da) | 2008-11-17 |
WO2004038428A2 (en) | 2004-05-06 |
ATE400819T1 (de) | 2008-07-15 |
AU2003275854B9 (en) | 2009-08-27 |
ECSP055748A (es) | 2005-08-11 |
AU2003275854A1 (en) | 2004-05-13 |
AU2003275854B2 (en) | 2008-09-11 |
CA2503361A1 (en) | 2004-05-06 |
DE60322091D1 (de) | 2008-08-21 |
HK1086475A1 (en) | 2006-09-22 |
NO20052515D0 (no) | 2005-05-25 |
KR101120729B1 (ko) | 2012-04-23 |
SI1558935T1 (sl) | 2008-12-31 |
WO2004038428A3 (en) | 2005-06-09 |
EP1558935A2 (en) | 2005-08-03 |
ES2310686T3 (es) | 2009-01-16 |
MXPA05004410A (es) | 2005-11-23 |
JP2006507276A (ja) | 2006-03-02 |
PT1558935E (pt) | 2008-10-16 |
BR0315657A (pt) | 2005-09-13 |
NZ539869A (en) | 2007-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052515L (no) | Frigjoringskontrollerte sammensetninger | |
ME00482B (me) | Čvrste farmaceutske kompozicije koje sadrže pregabalin sredstvo za formiranje matriksa i sredstvo za bubrenje | |
CO4700474A1 (es) | Formulacion oral de 2-metil-tieno-benzodiacepina | |
ME00391B (me) | Tableta bupropion hidrohlorida sa modifikovanim otpuštanjem | |
MX9707585A (es) | Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada. | |
RS54929B1 (sr) | Formulacija i metod obložene tablete | |
TWI235068B (en) | Sustained-release pharmaceutical composition | |
AR024492A1 (es) | Formas de dosificacion farmaceutica para liberacion controlada que comprenden al menos un impulso ciclico | |
JO2555B1 (en) | Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent | |
ATE455538T1 (de) | Retardtabletten mit hydromorphon | |
ZA200509477B (en) | Delayed release tablet with defined core geometry | |
TR200102880T2 (tr) | Enjekte edilebilir naltrekson mikrokre bileçimleri ve bunlarìn eroin ve alkol tketiminin azaltìmì iin kullanìmì | |
WO2007025182A3 (en) | Drug compositions containing controlled release hypromellose matrices | |
AR099437A2 (es) | Matriz para la liberación sostenida, invariable e independiente de compuestos activos | |
ATE185266T1 (de) | Schnell auflösende orale darreichungsform | |
MY142195A (en) | Controlled-release compositions | |
UA86929C2 (ru) | Композиция с контролируемым высвобождением | |
ATE479428T1 (de) | Olanzapin enthaltende pharmazeutische zusammensetzung | |
BRPI0315657B8 (pt) | formulação de dosagem sólida, comprimido para liberação controlada, método de fabricar uma medicação de liberação controlada, composição farmacêutica e uso de uma composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |